Literature DB >> 29290628

The role of SIRT6 in tumors.

Vanessa Desantis1, Aurelia Lamanuzzi1, Angelo Vacca2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29290628      PMCID： PMC5777184          DOI： 10.3324/haematol.2017.182675

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  24 in total

Review 1.  The complex role of SIRT6 in carcinogenesis.

Authors:  Batia Lerrer; Asaf A Gertler; Haim Y Cohen
Journal:  Carcinogenesis       Date:  2015-12-30       Impact factor: 4.944

Review 2.  Sirtuins in aging and age-related disease.

Authors:  Valter D Longo; Brian K Kennedy
Journal:  Cell       Date:  2006-07-28       Impact factor: 41.582

Review 3.  SIRT6, a protein with many faces.

Authors:  Asaf A Gertler; Haim Y Cohen
Journal:  Biogerontology       Date:  2013-11-10       Impact factor: 4.277

4.  SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions.

Authors:  Abhishek Bhardwaj; Sanjeev Das
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

5.  SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.

Authors:  Long-Kuan Ran; Yong Chen; Zhen-Zhen Zhang; Na-Na Tao; Ji-Hua Ren; Li Zhou; Hua Tang; Xiang Chen; Ke Chen; Wan-Yu Li; Ai-Long Huang; Juan Chen
Journal:  Clin Cancer Res       Date:  2016-02-09       Impact factor: 12.531

6.  The histone deacetylase SIRT6 inhibits ovarian cancer cell proliferation via down-regulation of Notch 3 expression.

Authors:  J Zhang; X-J Yin; C-J Xu; Y-X Ning; M Chen; H Zhang; S-F Chen; L-Q Yao
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015       Impact factor: 3.507

7.  SIRT6 promotes COX-2 expression and acts as an oncogene in skin cancer.

Authors:  Mei Ming; Weinong Han; Baozhong Zhao; Nagalingam R Sundaresan; Chu-Xia Deng; Mahesh P Gupta; Yu-Ying He
Journal:  Cancer Res       Date:  2014-10-15       Impact factor: 12.701

8.  A miR-34a-SIRT6 axis in the squamous cell differentiation network.

Authors:  Karine Lefort; Yang Brooks; Paola Ostano; Muriel Cario-André; Valérie Calpini; Juan Guinea-Viniegra; Andrea Albinger-Hegyi; Wolfram Hoetzenecker; Ingrid Kolfschoten; Erwin F Wagner; Sabine Werner; Gian Paolo Dotto
Journal:  EMBO J       Date:  2013-07-16       Impact factor: 11.598

9.  SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b.

Authors:  Sita Kugel; Carlos Sebastián; Julien Fitamant; Kenneth N Ross; Supriya K Saha; Esha Jain; Adrianne Gladden; Kshitij S Arora; Yasutaka Kato; Miguel N Rivera; Sridhar Ramaswamy; Ruslan I Sadreyev; Alon Goren; Vikram Deshpande; Nabeel Bardeesy; Raul Mostoslavsky
Journal:  Cell       Date:  2016-05-12       Impact factor: 41.582

10.  Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.

Authors:  Antonia Cagnetta; Debora Soncini; Stefania Orecchioni; Giovanna Talarico; Paola Minetto; Fabio Guolo; Veronica Retali; Nicoletta Colombo; Enrico Carminati; Marino Clavio; Maurizio Miglino; Micaela Bergamaschi; Aimable Nahimana; Michel Duchosal; Katia Todoerti; Antonino Neri; Mario Passalacqua; Santina Bruzzone; Alessio Nencioni; Francesco Bertolini; Marco Gobbi; Roberto M Lemoli; Michele Cea
Journal:  Haematologica       Date:  2017-10-12       Impact factor: 9.941
View more
  14 in total

Review 1.  Subcellular compartmentalization of NAD+ and its role in cancer: A sereNADe of metabolic melodies.

Authors:  Yi Zhu; Jiaqi Liu; Joun Park; Priyamvada Rai; Rong G Zhai
Journal:  Pharmacol Ther       Date:  2019-04-08       Impact factor: 12.310

2.  The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer.

Authors:  Qiai You; Jianmin Wang; Yongxin Yu; Feng Li; Lingxin Meng; Mingjing Chen; Qiao Yang; Zihan Xu; Jianguo Sun; Wenlei Zhuo; Zhengtang Chen
Journal:  Apoptosis       Date:  2022-08-01       Impact factor: 5.561

Review 3.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

Review 4.  Emerging roles of SIRT6 in human diseases and its modulators.

Authors:  Gang Liu; Haiying Chen; Hua Liu; Wenbo Zhang; Jia Zhou
Journal:  Med Res Rev       Date:  2020-12-16       Impact factor: 12.944

5.  Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemia.

Authors:  Hetty E Carraway; Sridhar A Malkaram; Yana Cen; Aymen Shatnawi; Jun Fan; Hamdy E A Ali; Zakaria Y Abd Elmageed; Thomm Buttolph; James Denvir; Donald A Primerano; Tamer E Fandy
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379

6.  The clinical and prognostic significance of FOXN3 downregulation in acute myeloid leukaemia.

Authors:  Jinjing Zhang; Yue Wang; Wenbin Mo; Rui Zhang; Yan Li
Journal:  Int J Lab Hematol       Date:  2020-02-20       Impact factor: 2.877

7.  Sirtuin 1 Inhibiting Thiocyanates (S1th)-A New Class of Isotype Selective Inhibitors of NAD+ Dependent Lysine Deacetylases.

Authors:  Nathalie Wössner; Zayan Alhalabi; Jessica González; Sören Swyter; Jin Gan; Karin Schmidtkunz; Lin Zhang; Alejandro Vaquero; Huib Ovaa; Oliver Einsle; Wolfgang Sippl; Manfred Jung
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

8.  NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma.

Authors:  Hong-Zhong Zhou; Han-Qing Zeng; Ding Yuan; Ji-Hua Ren; Sheng-Tao Cheng; Hai-Bo Yu; Fang Ren; Qing Wang; Yi-Ping Qin; Ai-Long Huang; Juan Chen
Journal:  Cell Commun Signal       Date:  2019-12-16       Impact factor: 5.712

Review 9.  The "ART" of Epigenetics in Melanoma: From histone "Alterations, to Resistance and Therapies".

Authors:  Thomas Strub; Robert Ballotti; Corine Bertolotto
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

Review 10.  A Molecular Perspective on Sirtuin Activity.

Authors:  Carla S S Teixeira; Nuno M F S A Cerqueira; Pedro Gomes; Sérgio F Sousa
Journal:  Int J Mol Sci       Date:  2020-11-15       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.